Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Monster Beverage Corp (MNST) Price & Performance

GE HealthCare Technologies Inc. Common StockTrade
Monster Beverage CorpTrade

Price performance (Past 24H)

Key statistics

GE HealthCare Technologies Inc. Common Stock vs Monster Beverage Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Monster Beverage Corp trades at $44.83 (market cap $86.63B). The key difference: Monster Beverage Corp is far larger — about 2.8× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals.

GEHCMNST
Market Cap
$30.93B$86.63B
Volume
5,033,45111,197,663
Sector
HealthConsumer Staples
52-Week High
$88.16$49.97
52-Week Low
$59.48$33.16
Enterprise Value
$39.39B$84.92B
Dividend Yield
0.23%—
Typical Hold Time
—72 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Monster Beverage Corp

Monster Beverage (MNST) trades at $43.31, down 1.03% today, with a bullish technical signal supported by moving averages. The company demonstrates strong fundamentals with 2025 revenue of $8.29B, net income of $1.91B (23.08% margin), and consistent earnings beats in recent quarters. Recent news highlights international expansion success and a debt-free balance sheet as key strengths, while a 1:2 stock split occurred in August 2026.

MNST presents a compelling growth story with robust profitability and international momentum, though elevated valuation multiples (P/E 40.1) warrant caution. Analyst consensus remains positive with a $98.22 price target (52.27% buy ratings), but regulatory challenges in key markets like India and competitive pressures represent ongoing risks for investors.

Returns comparison

Trailing returns across standard periods

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →

About Monster Beverage Corp

Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.

Read more on MNST →